C Sanjuás1. Show Affiliations » 1. Servei de Pneumologia. Hospital del Mar. Barcelona. Spain. Csanjuas@imas.imim.es
Abstract
Entities: Disease
Mesh： See more » Albuterol/administration & dosageAlbuterol/analogs & derivativesAlbuterol/therapeutic useBronchodilator Agents/administration & dosageBronchodilator Agents/therapeutic useClinical Trials as TopicDyspnea/etiologyEmotionsExerciseFollow-Up StudiesForced Expiratory VolumeHealth StatusHumansInterviews as TopicIpratropium/administration & dosageIpratropium/therapeutic useMultivariate AnalysisPlacebosPulmonary Disease, Chronic Obstructive/complicationsPulmonary Disease, Chronic Obstructive/drug therapyPulmonary Disease, Chronic Obstructive/physiopathologyPulmonary Disease, Chronic Obstructive/psychologyPulmonary Disease, Chronic Obstructive/rehabilitationQuality of LifeSalmeterol XinafoateScopolamine Derivatives/administration & dosageScopolamine Derivatives/therapeutic useSurveys and QuestionnairesTime FactorsTiotropium Bromide
Substances： See more » Bronchodilator AgentsPlacebosScopolamine DerivativesSalmeterol XinafoateIpratropiumAlbuterolTiotropium Bromide
Year: 2002 PMID： 12372199 DOI： 10.1016/s0300-2896(02)75270-8
Source DB: PubMed Journal: Arch Bronconeumol ISSN： 0300-2896 Impact factor: 4.872